KOLANUT CAN CURE EBOLA-PROF. MAURICEWU
A plant has been found
to halt the deadly Ebola virus in its tracks in laboratory tests, scientists
have said.
They used a compound
from Garcinia kola, a plant commonly eaten in West Africa. Compounds from the
plant have also proved effective against some strains of flu.
If the anti-Ebola
compound proves successful in animal and human trials, it will be the first
medicine to successfully treat the virus that causes Ebola haemorrhagic fever –
an often-fatal condition.
The discovery was
announced at the 16th International Botanical Congress in St Louis in the US.
Four deaths per five
cases
The Ebola virus was
first documented in 1976 after an outbreak in Zaire – now the Democratic
Republic of the Congo – where 88 per cent of the 318 human cases died.
More recently, a 1995
outbreak in the same country had a death rate of 81% of the 315 infected.
There are four types of
the virus – Ebola-Zaire, Ebola-Sudan and Ebola-Ivory Coast all affect humans,
while Ebola-Reston has so far only affected monkeys and chimpanzees.
However, doctors have
been unable to stop the virus once infection has taken hold – hence the disease
has gained a terrifying reputation.
Traditional origins
Dr. Maurice Iwu, who set
up and heads the Bioresources Development and Conservation Programme, led the
research.
It started 10 years ago
when researchers were led to the plant by traditional native healers who have
used the plant for the treatment of infectious diseases for centuries.
“This is a very exciting
discovery,” said Dr. Iwu, who himself comes originally from a family of
traditional healers.
“The same forest that
yields the dreaded Ebola virus could be a source of the cure.”
Fighting chance
The virus multiplies
rapidly in the human body and quickly overwhelms it, and in advanced cases the
patient develops high fever and severe bleeding.
The Garcinia kola
compound has been shown to halt multiplication of the virus in the laboratory.
If repeated in humans, this would give the body a chance to fight off the
virus.
The active compound is
what is known as a dimeric flavonoid, which is two flavonoid molecules fused
together.
Flavonoids are non-toxic
and can be found in orange and lemon rinds as well as the colourings of other
plants.
Drug hopes
The tests are in the
early stages still, but the researchers hope that if they continue to prove
successful the compound the US Food and Drug Administration will put it on a
fast track – making a drug available to humans within a matter of years.
“The discovery of these
important properties in a simple compound – flavonoids – was very surprising,”
said Dr. Iwu.
“The structure of this
compound lends itself to modification, so it provides a template for future work.
“Even if this particular
drug does not succeed through the whole drug approval process, we can use it to
construct a new drug for this deadly disease.”
.This article was first published by the British Broadcasting Corporation on August 5, 1999 when Prof. Maurice Iwu was still Dr. Maurice Iwu. Prof. Iwu was a former Chairman of the Independent National Electoral Commission. He has since returned to his first love of researching after his service at INEC.
No comments:
Post a Comment